Sincere Co., LTD. (TYO:7782)
Japan
· Delayed Price · Currency is JPY 653.00
+5.00 (0.77%)
Apr 24, 2025, 3:30 PM JST
Sincere Co., LTD. Revenue
In the year 2024, Sincere Co., LTD. had annual revenue of 6.54B JPY with 9.70% growth. Sincere Co., LTD. had revenue of 1.69B in the quarter ending December 31, 2024, with 12.63% growth.
Revenue
6.54B
Revenue Growth
+9.70%
P/S Ratio
0.64
Revenue / Employee
118.89M
Employees
55
Market Cap
4.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.54B | 578.00M | 9.70% |
| Dec 31, 2023 | 5.96B | 376.00M | 6.73% |
| Dec 31, 2022 | 5.59B | 1.03B | 22.56% |
| Dec 31, 2021 | 4.56B | 369.00M | 8.81% |
| Dec 31, 2020 | 4.19B | -180.00M | -4.12% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,170.61B |
| Takeda Pharmaceutical Company | 4,579.02B |
| Daiichi Sankyo Company | 1,795.99B |
| HOYA Corporation | 838.60B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,329.86B |
| Astellas Pharma | 1,867.63B |
| Shionogi & | 456.87B |